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By using a radioimmunoassay for the sequence Arg-Phe-amide, the peptide pGlu-Gly-Arg-Phe-amide was 
isolated from the pennatulid Renilla kiillikeri and sequenced. This peptide is a neuropeptide and is produced 
in high amounts in Renilla tissue (10 nmol/g wet wt). 
Peptide isolation; Neuropeptide; Neurotransmitter; Evolution 
1. INTRODUCTION 
Coelenterates have the simplest nervous systems 
of the animal kingdom, and it was probably within 
this group of animals that nervous systems first 
evolved. From ultrastructural and electrophys- 
iological investigations, it has become evident that 
neurotransmission in coelenterates is mainly 
chemical (reviews [l-3]). However, the nature of 
transmitter substances in coelenterates has long re- 
mained unknown. Recently, using immunocyto- 
chemistry with antisera to the sequence Arg-Phe- 
amide (RFamide), RFamide-like peptides could be 
demonstrated in the nervous systems of a variety 
of coelenterates [2-61. Using a radioimmunoassay 
for RFamide, one such peptide, pGlu-Gly-Arg- 
Phe-amide, could be isolated and sequenced from 
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The structure of the anthozoan neuropeptide pGlu-Gly- 
Arg-Phe-amide has been published in the proceedings of 
the following meetings: ‘Invertebrate Peptides and 
Amines’ (Bordeaux, April 1986), ‘14. Neurobiologen- 
tagung’ (Giittingen, May 1986), ‘Nervous Systems in In- 
vertebrates’ (Lennoxville, July 1986) and the ‘13th 
Conference of European Comparative Endocrinologists’ 
(Belgrade, September 1986) 
the sea anemone Anthopleura elegantissima [7]. 
Here, we have isolated an RFamide-like peptide 
from the pennatulid Renilla kdlikeri. The pen- 
natulids (order Pennatulacea) and sea anemones 
(order Actinaria) are phylogenetically widely 
separated coelenterates, both belonging to the class 
of Anthozoa. 
2. MATERIALS AND METHODS 
R. kdlikeri, harvested in May 1985, were pur- 
chased from Biomarine Laboratories (Venice, 
USA) and shipped on dry ice to Heidelberg. The 
same acetic acid extraction was carried out as 
described earlier for sea anemones [7], with the on- 
ly modification being that far more acetic acid was 
needed to bring the homogenate to pH 3.2 (due to 
the presence of calcareous spicules in Renilla). 
Also the desalting procedure using Sep-pak, the 
cation-exchange chromatography using CM- 
Sephadex C-25, and details of the radioim- 
munoassay were described before [7]. The 
radioimmunoassay for RFamide has a high affini- 
ty for all peptides terminating with Arg-Phe- 
amide. Other peptides are only recognized (with a 
much lower efficiency), if they contain a carboxy- 
terminal amidation, as well as an uncharged 
aromatic or aliphatic amino acid in the carboxy- 
terminal position, preceded by Arg or Lys [2,7]. 
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HPLC was carried out with a Shimadzu LCdA 
system; the HPLC columns were described earlier 
[7]. The amino acid composition of the peptide 
was determined by hydrolysis (6 N HCl, overnight 
at 115”Q subsequent dansylation and separation 
of the dansylated products on 2.5 x 2.5 cm 
polyamide sheets [7-91. The stoichiometry of the 
amino acids was determined with an LKB amino 
acid analyzer using post-column derivatization 
with ninhydrin. Sequencing was carried out with 
the 4-N,N-dimethylaminoazobenzene 4’-isothio- 
cyanate (DABITC) method [lo]. Enzymatic 
removal of pyroglutamate was performed by ad- 
ding 6 mU pyroglutamate aminopeptidase (EC 
3.4.19.3; from Serva, Heidelberg) to IO-20 nmol 
peptide dissolved in 50 ~1 freshly prepared 0.1 M 
NaHCO3. After incubation for 1 h at 37°C the 
reaction was stopped by addition of 50~1 of 2 M 
acetic acid, followed by lyophilization and 
purification by HPLC (fig.5). pGlu-Gly-Arg-Phe- 
amide was prepared as a customer synthesis by 
Bachem (Bubendorf). 
Fig. 1. Cation-exchange chromatography of an acetic 
acid extract of 1.5 kg R. kdlikeri (after desalting using 
Sep-pak 171). The column (2.5 x 40 cm; void volume 
75 ml) contained CM-Sephadex C-25 equilibrated with 
0.1 M ammonium acetate, pH 7. After application of 
100 ml sample, the column was rinsed with 220 ml 
buffer. Subsequently, a linear gradient of 0.1-3.0 M 
ammonium acetate (pH 7) was started. Several 
immunoreactive components were eluted between 1.2 
and 2.4 M salt. These components were pooled (28 pmol 
3. RESULTS RFamide equivalents). 
Using a radioimmunoassay for RFamide, high 
amounts of immunoreactive material could be 
measured in acetic acid extracts of R. kdlikeri. 
This material was retained on Sep-pak and could 
be eluted with 60% methanol [7]. By this pro- 
cedure, the immunoreactive material was desalted, 
considerably purified and concentrated. After 
removal of the methanol, the material was further 
purified by cation-exchange chromatography using 
a salt gradient (fig.1). The Renilla RFamide-like 
peptide strongly bound to the resin, and was eluted 
at high ammonium acetate concentrations, when 
most of the contaminating substances had been 
removed (fig.1). After desalting with Sep-pak [7], 
the immunoreactive material was further purified 
by cation-exchange chromatography, using dif- 
ferent pH values (figs 2,3). After these 
chromatographies, the material was pure enough 
to be analyzed by HPLC. Using a C-18 column 
and an acetonitrile gradient, the immunoreactive 
material was eluted as a single peak (fig.4). 
Rechromatography of this peak using different 
HPLC columns showed that this material was 
pure. 
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Fig.2. Cation-exchange chromatography of the pooled 
fractions of fig.1 (after desalting). A similar column to 
that in fig.1 was equilibrated with 0.3 M ammonium 
acetate, pH 8. After application of 60 ml sample, a 
linear gradient of 0.3-3.0 M ammonium acetate (pH 8) 
was started. A minor immunoreactive component was 
eluted at 1.0-l .2 M ammonium acetate (pooled, 
4 pmol) and a major component at 1.3-l .6 M (8 Fmol). 
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Fig.3. Cation-exchange chromatography of the major 
immunoreactive component of fig.2 (after desalting). A 
similar column to that in fig.1 was equilibrated with 
1.2 M ammonium acetate, pH 5. After application of 
77 ml sample, a linear gradient of 1.2 M (pH 9-2.0 M 
(pH 8) ammonium acetate was started. Immunoreac- 
tivity was eluted at 1.3-1.4 M ammonium acetate 
(7 pmol). 
Hydrolysis of the HPLC-purified material, 
followed by dansylation and chromatography of 
the dansylated amino acids, showed the following 
amino acids: Glu, Gly, Arg and Phe. End group 
determination using dansyl chloride did not reveal 
a reactive end group. As Glu was present in the 
hydrolysate, pyroglutamate (pGlu) could be the 
amino-terminus. Enzymatic digestion of the pep- 
tide with a low amount of pyroglutamate 
aminopeptidase, followed by HPLC, revealed a 
new peak of immunoreactive material (fig.5). This 
material contained Gly, Arg and Phe, but no 
longer any Glu. pGlu, therefore, is the amino- 
terminus of the peptide and no other glutamate or 
glutamine is present. Using an amino acid 
analyzer, the stoichiometry of the amino acids in 
the intact peptide was determined as 1: 1: 1: 1. As 
the peptide only contains one Glu, the other amino 
acids must also be present as single copies. From 
our knowledge of the specificity of the radioim- 
munoassay (see section 2 and [2,7]), by which only 
Gly-Arg-Phe-amide can be recognized and no 
other amidated combination of the three carboxy- 
terminal amino acids, the structure of the intact 
peptide has to be: pGlu-Gly-Arg-Phe-amide. This 
sequence was confirmed using the DABITC 
method. After enzymatic removal of pGlu, Gly 
was found as an end group and, after degradation 
: I 1 
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Fig.4. HPLC of a portion (500 nmol) of the 
immunoreactive material purified in fig.3 (after 
desalting). The column (Spherisorb ODS-2, 5pm 
particle size, 80 A pore size; dimensions: 4 x 250 mm) 
was equilibrated with 10% acetonitrile in 0.1% 
trifluoroacetic acid (TFA). After injection of the 
sample, a linear gradient of lo-60% acetonitrile in 0.1% 
TFA was started (20 min; 1 ml/min). The immunoreac- 
tive material was eluted as a single peak at 8.3 min 
(arrow). 
cycles, Arg and Phe-amide. 
The chromatographic behaviour of natural, 
purified Renilla peptide was compared with that of 
synthetic pGlu-Gly-Arg-Phe-amide, using HPLC 
and six different reversed-phase columns contain- 
ing material with different ligands (C-18, C-8, 
propyl-phenyl, propyl-nitrile) and different pore 
diameters (60-300 A). The natural and synthetic 
peptide were always eluted at exactly the same 
retention time (because of space problems this 
could not be shown, but cf. [7]). This further con- 
firmed the structure of the Renilla peptide. 
Using pGlu-Gly-Arg-Phe-amide as a standard in 
our radioimmunoassay, 15 -t 3 nmol/g wet wt of 
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Fig.5. HPLC after degradation of natural and synthetic 
peptide by pyroglutamate aminopeptidase (column: 
Partisil ODS-3, 5 pm, 60 A, 4 x 250 mm; gradient: 
20 min, 1 ml/min, lo-60% acetonitrile in 0.1% TFA). 
Intact, undigested peptide is eluted at 7.2 min [7]. (a) 
Degradation product of 15 nmol natural Renilla 
peptide. Only one peak is immunoreactive (5.813 min; 
arrow). This material is a peptide fragment which lacks 
glutamate (pGlu). (b) Degradation product of 20 nmol 
synthetic pGlu-Gly-Arg-Phe-amide. This material 
(arrow) is eluted at the same position as the degradation 
product of the natural peptide (5.792 min; retention- 
time variability is rf: 1%). 
immunoreactive material was measured in three 
different acetic acid extracts of Renilla. Corrected 
for the contribution of the ‘minor component’ 
(fig.2), the concentration of pGlu-Gly-Arg-Phe- 
amide in Renilla is 10 + 2 nmol/g. 
4. DISCUSSION 
pGlu-Gly-Arg-Phe-amide was isolated earlier 
from the sea anemone A. elegantissima [7]. Here, 
we have isolated and sequenced the same peptide 
from the pennatulid R. kdlikeri. As two, 
phylogenetically widely separated anthozoans pro- 
duce the same peptide, it is likely that this peptide 
occurs generally in anthozoans. 
Using antisera to the sequence Arg-Phe-amide, 
we have stained numerous neurons in Renilla, 
many of which were associated with muscles. Non- 
neuronal tissue was not stained by the antisera (not 
shown, but an extensive anatomical study is in 
preparation; cf. also [5,6]). The peptide pGlu-Gly- 
Arg-Phe-amide, therefore, is likely to be produced 
by neurons, and thus be a neuropeptide. 
pGlu-Gly-Arg-Phe-amide is present in high con- 
centrations in Renilla tissue (10 nmol/g wet wt). 
This concentration is 3-times higher than that of 
pGlu-Gly-Arg-Phe-amide in sea anemones and 
lOO-times higher than that of any neuropeptide in 
the mammalian brain [7]. This clearly illustrates 
that pGlu-Gly-Arg-Phe-amide must perform an 
important role in pennatulids. This role is 
unknown, but from its probable location in motor 
neurons, one function of the peptide could be that 
of a neurotransmitter at neuromuscular junctions. 
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